Jon Bigelow was named Executive Director of the Coalition for Healthcare Communication, succeeding John Kamp, who will continue his association with the Coalition as Washington Counsel.

The U.S. Food and Drug Administration announced a comprehensive policy framework for the development and oversight of regenerative medicine products, including novel cellular therapies.

Merck is globally committed to an antimicrobial stewardship encompassing surveillance, R&D, and health policy.